Monoclonal Antibody Shows Broad SARS-CoV-2 Neutralization in Preclinical Study Medical Countermeasures July 8, 2025 …
Integration Site Analysis During Long Term Follow-Up for Gene Therapies with Integrating Viral Vectors November 7, 2024 …
Humanetics Presents BIO 300 Radiation Countermeasure Data at DoD Scientific Meeting Medical Countermeasures October 3, 2024 …
Acurx Announces Anthrax Susceptibility to ACX-375 Analogues Medical Countermeasures September 26, 2024 …
RedHill Announces New Opaganib Chinese Patent Against Ebola Virus Valid Through 2035 Medical Countermeasures May 6, 2024 …
Primmune Therapeutics Awarded DTRA Funding for Lassa Fever Antiviral Medical Countermeasures March 20, 2024 …
Optimizing Medical Countermeasure Development: GUIDE Program Harnesses AI Against Biological Threats Medical Countermeasures February 28, 2024 …
BARDA Offers Preclinical Testing Assistance for Botulinum Neurotoxin Candidate Therapeutics Medical Countermeasures February 9, 2024 …
BARDA Funds Next Stage of CRISPR-Based Bacteriophage Therapy Medical Countermeasures January 23, 2024 …
NanoViricides’ Phase 1 Broad-Spectrum Antiviral Highly Effective for Mpox and Smallpox Medical Countermeasures November 14, 2023 …
DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development Industry News January 10, 2023 …
How Organ-on-a-chip Models Could Grease the Drug Development Pipeline Medical Countermeasures January 10, 2023 …
Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs Industry News June 20, 2022 …
ATCC Announces Awards from DTRA Supporting Global Health and Biodefense Industry News February 15, 2022 …
Zika Virus Vaccine Shows Promising Results in Preclinical Studies Medical Countermeasures February 6, 2022 …
Preclinical Studies Support Army’s Pan-Coronavirus Vaccine Development Strategy Medical Countermeasures December 16, 2021 …
